Table 1 Statistically significant protein-coding mutations in multiple myeloma

From: Initial genome sequencing and analysis of multiple myeloma

Gene

N

n

Untreated n

CpG transition

Other C:G transition

C:G transversion

A:T mutation

Indel/ null

P-value

q-value

NRAS

20,711

9

3

0

0

3

6

0

<1.0 × 10−11

<1.0 × 10−6

KRAS

25,728

10

6

0

5

1

4

0

<1.0 × 10−11

<1.0 × 10−6

FAM46C

39,661

5

3

0

0

2

1

2

1.8 × 10−10

1.0 × 10−6

DIS3

89,758

4

1

0

1

1

2

0

2.4 × 10−6

0.011

TP53

32,585

3

1

0

0

1

1

1

5.1 × 10−6

0.019

CCND1

12,899

2

1

0

0

0

2

0

0.000027

0.086

PNRC1

19,621

2

2

0

1

0

0

1

0.000039

0.094

ALOX12B

40,369

3

0

1

0

1

1

0

0.000042

0.094

HLA-A

18,635

2

0

0

0

0

2

0

0.000045

0.094

MAGED1

53,950

2

1

0

0

0

0

2

0.000053

0.10

  1. Territory (N) refers to total covered territory in base pairs across 38 sequenced samples. Total numbers of mutations (n) and numbers of mutations occurring in therapy-naive disease (Untreated n) are shown for each gene.